Article
A mood disorder complicated by multiple sclerosis
Ms. A, age 56, presents with depressed mood, anhedonia, irritability, agitation, and recent self-injurious behavior. She also has multiple...
Article
Urine drug screens: Not just for job applicants
Consider the urine drug screen as a tool for improving patients’ treatment adherence and clinical outcomes.
News
Study reveals long-term survival in MM patients
A retrospective study suggests one in seven patients with newly diagnosed multiple myeloma (MM) who are eligible for transplant may live at least...
News
The case for longer treatment in MM: Part 1
In Part 1 of this editorial, Katja Weisel, MD, of University Hospital Tubingen in Germany, describes the benefits of longer treatment in patients...
News
The case for longer treatment in MM: Part 2
In Part 2 of this editorial, Katja Weisel, MD, of University Hospital Tubingen in Germany, addresses the barriers to longer treatment in patients...
Article
Premenstrual Dysphoric Disorder: Diagnosis and Management in Primary Care
Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.
...
Opinion
Stay tuned
Two events that will impact our practices occurred in November: 1) an election and 2) the Centers for Medicare & Medicaid Services final rule...
News
FDA approves congenital CMV diagnostic test
The Alethia CMV Assay Test System detects CMV DNA obtained via a saliva swab.
News
What is your diagnosis? - December 2018
Clinical Challenges - December 2018
News
Firdapse approved: First treatment for rare autoimmune disorder
Amifampridine (Firdapse) has been approved by the FDA for Lambert-Eaton myasthenic syndrome, which affects the nerves’ connection with muscles.